BIRC5 and cancer: Survivin is an inhibitor of apoptosis protein (IAP) that is overexpressed in approximately 90 percent of human cancers1, 2, 3, 4 and is associated with tumour progression and poor prognosis,3,5, 6, 7, 8, 9, 10, 11 making survivin an attractive target for cancer therapy.3